Here are four notes:
1. NuVasive posted earnings per share of $0.35 for the third quarter of 2015.
2. Analysts have a consensus price target of $60.50 on NuVasive shares.
3. The shares have a broker recommendation of 1.53.
4. Three months ago, the stock also had a rating of 1.53.
More articles on devices:
Geisinger Health to pilot wearable technology tracking program: 5 points
Stryker acquires Sage Products for $2.7B — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.